Literature DB >> 30054751

Single-level vertebral kyphoplasty is not associated with an increased risk of symptomatic secondary adjacent osteoporotic vertebral compression fractures: a matched case-control analysis.

Henrik Teuber1, Simon Tiziani1, Sascha Halvachizadeh1, Diana Frey2, Kai Sprengel1, Hans-Christoph Pape1, Georg Osterhoff3.   

Abstract

This matched case-control study compared the rate of symptomatic adjacent-level vertebral compression fractures (VCF) within 1 year in patients operatively treated with kyphoplasty to a control group of non-operatively treated VCFs. The adjacent-level fracture rate did not show a significant difference between groups.
PURPOSE: To compare the rate of new symptomatic adjacent-level fractures within 1 year after an isolated osteoporotic vertebral compression fracture (VCF) treated by either kyphoplasty or non-operative treatment.
METHODS: Patients aged ≥ 50 years with an isolated, fresh, and symptomatic osteoporotic VCF who were treated by kyphoplasty were compared to patients of similar age, gender, vertebral segment, and bone mineral density who were treated non-operatively (n = 98). A matched case-control analysis was conducted by retrospective chart review, and the rate of new adjacent-level symptomatic vertebral fractures, defined as occurring within two segments of the index fracture, within the first year was determined.
RESULTS: Ninety-eight patients (66 female, aged 73.5, SD 9.7 years) were analyzed in this matched case-control study. The adjacent fracture rate within 1 year was not different between the kyphoplasty group and the non-operative group (20.4 vs 18.4%; McNemar, p = 1.0). The time to a new adjacent fracture after the index fracture was significantly shorter in the kyphoplasty (7, SD 8 weeks) versus non-operative group (22, SD 13 weeks).
CONCLUSIONS: Patients with osteoporotic VCFs treated with kyphoplasty did not show an increased rate of additional symptomatic adjacent-level VCFs when compared to a non-operative control group matched for age, gender, fracture level, and bone mineral density. LEVEL OF EVIDENCE: Level III.

Entities:  

Keywords:  Adjacent vertebral fracture; Adjacent-level vertebral fracture; Bone mineral density; Dual energy X-ray absorptiometry; Kyphoplasty; Osteoporosis; Spinal fracture; Vertebral compression fracture

Mesh:

Year:  2018        PMID: 30054751     DOI: 10.1007/s11657-018-0489-6

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  5 in total

1.  Timing of symptomatic subsequent vertebral compression fracture associated with different demographic factors.

Authors:  Yi-Chen Hsieh; Yi-Shan Yang; Li-Nien Chien; Yung-Hsiao Chiang; Jiann-Her Lin
Journal:  Eur Spine J       Date:  2022-07-11       Impact factor: 2.721

2.  [Hounsfield units as a measure of bone density-applications in spine surgery].

Authors:  Max J Scheyerer; Bernhard Ullrich; Georg Osterhoff; Ulrich A Spiegl; Klaus J Schnake
Journal:  Unfallchirurg       Date:  2019-08       Impact factor: 1.000

3.  Impact of Multifidus Muscle Atrophy on the Occurrence of Secondary Symptomatic Adjacent Osteoporotic Vertebral Compression Fractures.

Authors:  Georg Osterhoff; Garnik Asatryan; Ulrich J A Spiegl; Christian Pfeifle; Jan-Sven Jarvers; Christoph-E Heyde
Journal:  Calcif Tissue Int       Date:  2021-10-15       Impact factor: 4.333

Review 4.  Osteoporotic mid-thoracic vertebral body fractures: what are the differences compared to fractures of the lumbar spine?-a systematic review.

Authors:  Ulrich Josef Spiegl; Max Joseph Scheyerer; Georg Osterhoff; Sebastian Grüninger; Klaus John Schnake
Journal:  Eur J Trauma Emerg Surg       Date:  2021-09-29       Impact factor: 2.374

5.  Risk factors of new vertebral compression fracture after percutaneous vertebroplasty or percutaneous kyphoplasty.

Authors:  Yuanpei Cheng; Xiaokang Cheng; Han Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.